|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, November 17, 2017 ) Market Scenario:
“Flu Vaccine Market Outlook 2024: United States Opportunity and Demand Analysis, Market Forecast 2017-2024” provides a deep and thorough evaluation of the United States Flu Vaccine market. The report provides an in–depth analysis of the flu vaccination pattern in both Children and Adults in the United States. It also provides essential insights into flu vaccine production, price, consumption, supply, distribution, demand and specification. It also covers reimbursement pattern and offers a clear view of the regulatory landscape. Additionally, the report includes assessment of clinical trials and promising flu vaccines in the clinical development. Key trends in terms of M&A, collaborations and licensing agreements are analyzed with details.
United States flu vaccine market is expected to reach nearly US$ 3 Billion by 2024. Growth in US flu vaccine market can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against flu vaccine and introduction of quadrivalent flu vaccine.
Long–term Growth Projection and Development:
• Sanofi to Acquire Protein Sciences Corporation
• It is likely that more than 185 Million persons being vaccinated with flu vaccines in 2024.
• Nearly 160 Million doses of flu vaccines have shipped to US for the 2017-2018 flu season
• It is projected that GSK flu vaccine sales value will reach around US$ 1.5 Billion by 2024
• BiondVax reports positive phase 2b clinical trial results for its universal flu vaccine
Download Sample Copy @ https://www.precisemarketreports.com/report/sample/pmr-17436
The report concludes with the profiles of major players in the US flu vaccine market such as Sanofi Pasteur, GSK and Seqirus. The major market players are evaluated on various parameters such as company overview, product outlook, latest development & trends and sales analysis of flu vaccine market from 2011 to 2022. The report also entails major drivers and inhibitors in the US flu vaccine market.
Key Benefits
• This report gives a broad investigation of the present and developing business sector patterns and elements in the United States Flu Vaccine Market.
• Inside and out investigation is directed by developing business sector estimations for the key market estimations in the vicinity of 2017 and 2024.
• This study evaluating competitive landscape and value chain is taken into account to help understand the competitive environment across the geographies.
• Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
• This report gives the quantitative analysis of the present market and estimations through 2017-2024, which helps with distinguishing the overarching market openings
• Complete examination of all regions are given that decides the predominant open doors in these geographies.
Enquiry before buy @ https://www.precisemarketreports.com/report/enquiry/pmr-17436
Major Flu Vaccines Covered Under This Report Are:
• Fluzone High–Dose
• Fluzone Quadrivalent
• Intradermal (ID) Trivalent
• Vaxigrip
• Fluarix Quadrivalent
• Flulaval Quadrivalent
• Flucelvax Quadrivalent
• Afluria Quadrivalent
• Agrippal
• Fluad
• Fluvirin
• Fluvax
For the better understanding of the market, after arriving to the overall market size, the analyst were able to precisely split the market into several segments. The broken-down market research report served as a basis to understand the movements of Flu Vaccine market in the United States landscape and double checked data is presented to support every argument. Hence, the analysts were able to arrive to an up-to-standard conclusion of the market movements and were able to deliver a fair report on the growth projection of the United States Flu Vaccine market.
For Purchase this report visit @ https://www.precisemarketreports.com/paypal/checkout/pmr-17436
About us:
Precise market reports, a one-stop research platform designed to help key decision makers and dynamic thought leaders across various industry verticals United States by making them aware of the past, current and future market scenario.
Tier 1's, SME's startups, top management consultants, have clearly visualized their environment using our analysis, thus enabling them to make critical business decisions and in devising a strategic plan.
Contact us:
Precise Market Reports
Office No. 48, Akshya Complex, Dhole Patil road,
Maharashtra, Pune – 411001
India.
sales@precisemarketreports.com
+1 (323) 744 6588
https://www.precisemarketreports.com
Precise Market Reports
Ashish M
+1 (323) 744 6588
sales@precisemarketreports.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
